Armenian Translation

There is a growing demand for option of diagnostic tests.

BD and Alverix partner to develop point of treatment infectious disease diagnostic assay systems As customers begin to take greater ownership of their personal healthcare, there is a growing demand for option of diagnostic tests. Alverix, Inc. And BD are on the cutting edge of this craze and today announced an contract to create assay systems at the point-of-care that may improve infectious disease diagnoses. Until now, this known degree of performance required expensive, bench-top instrumentation. In contrast, Alverix’s detection products provide immediate, accurate results at POC – in doctors’ offices – for a fraction of the cost and turn around time of traditional methods. Related StoriesGenCell Biosystems acquired by Becton, Dickinson and CompanyBD announces completion of CareFusion acquisitionBD Life Sciences announces FDA clearance for BD MAX Enteric Parasite Panel’The price and efficiency of critical diagnoses will be greatly augmented as even more diagnostic tests are performed more quickly at the idea of care,’ said Ric Tarbox, CEO of Alverix.Taken together, these results suggest that the human being amygdala is definitely a pivotal section of the brain for triggering a state of fear.’ Feinstein said he was most amazed at what occurred when SM was presented with snakes and spiders in an exotic pet store. ‘For many years, SM has been telling us that she ‘hates’ snakes and spiders and ‘tries to avoid them.’ Entering the experiment, everyone, including myself, thought SM would stay away from these animals. Yet, to our surprise, she immediately started touching them! When asked why she was touching something that she statements to hate, she appeared perplexed by her own behavior and mentioned that she was overcome with curiosity. It had been as if the area of the brain in charge of SM’s cognition and thoughts was totally disconnected from the section of the mind controlling her behavior.’ Feinstein says the brand new findings claim that methods designed to securely and non-invasively turn off the amygdala might keep promise for those experiencing post-traumatic stress disorder .